From time to time, investors in the Indian stock market get the opportunity to invest in IPOs. Sai Parenterals Company's issue is also set to open soon. Let's learn more about it...
Another opportunity for investors...
Sai Parenterals IPO: From time to time, investors in the Indian stock market get the opportunity to invest in Initial Public Offerings (IPOs). Sai Parenterals' issue is also set to open soon. The company has provided information about the price band. Let's learn more about this new issue...
When will the issue open, and what related information
Sai Parenterals' offering is seeking to raise a total of ₹408.79 crore (approximately $1.2 billion) through its issue. The issue is being conducted through a book-building process. This includes a fresh issue of ₹285 crore (approximately $1.7 million) of new shares. An offer for sale (OFS) of ₹123.79 crore (approximately $1.2 billion) will also be part of the IPO.
Approximately 50% of the company's shares in the IPO are reserved for QIBs, 35% for retail investors, and 15% for NIIs. The IPO will open for subscription on March 24th. Investors can place their bets until March 27th.
The share allotment is expected to take place on March 30. Following this, the company's shares may be listed on the Bombay Stock Exchange (BSE) and National Stock Exchange (NSE) on April 2.
What is a price band?
The company has set a price band of ₹372-₹392 per share for this issue. A lot size of 38 shares has been set. This means that retail investors will need to make a minimum lump sum investment of ₹14,896.
company financial figures
Looking at recent financial data, the company reported revenue of ₹163.74 crore for the fiscal year 2025, while profits were ₹14.43 crore. Furthermore, as of September 30, 2025, the company's EBITDA reached ₹16.24 crore, and total assets were recorded at ₹376.24 crore.
The company's net worth during the same period was ₹209.37 crore, while total borrowings were recorded at ₹76.07 crore, reflecting the company's current financial position.
